- call +1-201-465-4211
- email sales@mrinsights.biz
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
Scope of the Report:
This report studies the Crohn’s Disease Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Crohn’s Disease Therapeutics market by product type and applications/end industries.
Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market.
The global Crohn’s Disease Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Crohn’s Disease Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Johnson & Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Non-Surgical
Surgical
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Crohn’s Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Crohn’s Disease Therapeutics
1.2 Classification of Crohn’s Disease Therapeutics by Types
1.2.1 Global Crohn’s Disease Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Types in 2017
1.2.3 Non-Surgical
1.2.4 Surgical
1.3 Global Crohn’s Disease Therapeutics Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Crohn’s Disease Therapeutics Market by Regions
1.4.1 Global Crohn’s Disease Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Crohn’s Disease Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Crohn’s Disease Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Crohn’s Disease Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Crohn’s Disease Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Crohn’s Disease Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Crohn’s Disease Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Johnson & Johnson Services Inc.
2.1.1 Business Overview
2.1.2 Crohn’s Disease Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer Inc.
2.2.1 Business Overview
2.2.2 Crohn’s Disease Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Allergan
2.3.1 Business Overview
2.3.2 Crohn’s Disease Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 AbbVie Inc.
2.4.1 Business Overview
2.4.2 Crohn’s Disease Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Takeda Pharmaceutical Company Limited
2.5.1 Business Overview
2.5.2 Crohn’s Disease Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Celgene Corporation
2.6.1 Business Overview
2.6.2 Crohn’s Disease Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Perrigo Company PLC
2.7.1 Business Overview
2.7.2 Crohn’s Disease Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Ferring B.V.
2.8.1 Business Overview
2.8.2 Crohn’s Disease Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Salix Pharmaceuticals
2.9.1 Business Overview
2.9.2 Crohn’s Disease Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Gilead Sciences Inc.
2.10.1 Business Overview
2.10.2 Crohn’s Disease Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genentech Inc.
2.11.1 Business Overview
2.11.2 Crohn’s Disease Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 UCB India Private Limited.
2.12.1 Business Overview
2.12.2 Crohn’s Disease Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Crohn’s Disease Therapeutics Market Competition, by Players
3.1 Global Crohn’s Disease Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Crohn’s Disease Therapeutics Players Market Share
3.2.2 Top 10 Crohn’s Disease Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Crohn’s Disease Therapeutics Market Size by Regions
4.1 Global Crohn’s Disease Therapeutics Revenue and Market Share by Regions
4.2 North America Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Crohn’s Disease Therapeutics Revenue by Countries
5.1 North America Crohn’s Disease Therapeutics Revenue by Countries (2013-2018)
5.2 USA Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Crohn’s Disease Therapeutics Revenue by Countries
6.1 Europe Crohn’s Disease Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Crohn’s Disease Therapeutics Revenue by Countries
7.1 Asia-Pacific Crohn’s Disease Therapeutics Revenue by Countries (2013-2018)
7.2 China Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Crohn’s Disease Therapeutics Revenue by Countries
8.1 South America Crohn’s Disease Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Crohn’s Disease Therapeutics by Countries
9.1 Middle East and Africa Crohn’s Disease Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Crohn’s Disease Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Crohn’s Disease Therapeutics Market Segment by Type
10.1 Global Crohn’s Disease Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Crohn’s Disease Therapeutics Market Forecast by Type (2018-2023)
10.3 Non-Surgical Revenue Growth Rate (2013-2023)
10.4 Surgical Revenue Growth Rate (2013-2023)
11 Global Crohn’s Disease Therapeutics Market Segment by Application
11.1 Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Crohn’s Disease Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 Global Crohn’s Disease Therapeutics Market Size Forecast (2018-2023)
12.1 Global Crohn’s Disease Therapeutics Market Size Forecast (2018-2023)
12.2 Global Crohn’s Disease Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Crohn’s Disease Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Crohn’s Disease Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Crohn’s Disease Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Crohn’s Disease Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Crohn’s Disease Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Crohn’s Disease Therapeutics Picture
Table Product Specifications of Crohn’s Disease Therapeutics
Table Global Crohn’s Disease Therapeutics and Revenue (Millio
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
